Already have a Username/Password for Molecular and Cellular Pharmacology?
Go to Login
Need a Username/Password?
Go to Registration
Registration and login are required to submit items online and to check the status of current submissions.
Instructions to Authors
Aims and Scope. Molecular and Cellular Pharmacology publishes manuscripts in all areas broadly related to Pharmacological Sciences. Areas of focus include, but are not limited to, molecular and cellular basis of drug actions including effects of pharmacological agents on gene regulation, chromosome structure and dynamics, protein function and modification, signal transduction, cell death and survival, and intracellular trafficking; drug design and discovery; pharmacogenomics and pharmacoproteomics; clinical pharmacology including pharmacokinetics, pharmacodynamics, pathways of drug metabolism, and drug-drug interactions; immunopharmacology including immunotherapy, immunotoxicology, and immunopathology; toxicology including toxicokinetics and toxicodynamics; radiopharmacology including radiopharmaceuticals, development and characterization of novel imaging agents, and radiation and drug interactions.
Original Research Articles and Reviews will be considered for publication with the explicit understanding that such manuscripts have not been previously published or being considered for publication by another journal. It is preferred that manuscripts be submitted via the online submission system at www.mcpharmacol.com. Authors using the online submission system for the first time will have the opportunity to register with the Journal online. If authors are unable to use the online submission system, they can email their manuscripts (in PDF format) to the editorial office at email@example.com.
Manuscript Organization. Authors are advised to be succinct and avoid grammatical and typographical errors. Authors should also ensure that their manuscripts conform to the Journal guidelines. All Original Research Articles can be divided into the following sections:
Title Page. The title should be informative and not too long. Full names and complete affiliations of all authors should be included. A running title, 6 keywords and name, full address including telephone/fax numbers, and e-mail address of the corresponding author should also be provided.
Abstract. The abstract should be succinct and of no more than 250 words.
Text. Text should be divided into Introduction, Materials and Methods and Discussion. Acknowledgments and information on ‘Conflicts of Interest’ should follow the ‘Discussion’ page. The Journal supports humane treatment of animals and requires that all investigations involving animals must follow the institutional, local, national and international standards. A statement to this effect must be included in Materials and Methods section. The Journal adheres to the Declaration of Helsinki and requires that research involving human subjects must be conducted according to the institutional, local, national and international guidelines. A statement to this effect must also be included in Materials and Methods section.
Conflict of Interest. The Journal requires that authors and reviewers disclose any actual or potential conflicts of interest.
References. References should be numbered consecutively in the order of their mention in the text. The Journal has adopted the guidelines of International Committee of Medical Journal Editors (ICMJE) on reference citations. More information can be found at (www.nlm.nih.gov/bsd/uniform_requirements.html), the National Library of Medicine and at (www.icmje.org), International Committee of Medical Journal Editors.
Journal articles should be cited as:
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-7.
If more than six authors, list the first three and then et al. For example,
Rose ME, Huerbin MB, Melick J, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res 2002;935:40-6.
Chapter in a book should be cited as:
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
Tables. An informative title for each table is required.
Figures. Figures should be numbered consecutively in the order of their mention in the text. It is authors’ responsibility to provide high-quality digital illustrations for clear reproduction; acceptable formats include TIFF, PNG or PowerPoint. However, to expedite the peer-review process, authors can submit the entire manuscript in the PDF format for review-only.
Figure Legends. A legend must be provided for each figure. Legends should be brief and informative.
PharmSights. The Journal will also publish PharmSight pieces in each issue. The Editors will invite authors of significant recent articles published in the Pharmacology literature to write overview of their published work. Authors will have the opportunity to provide additional insights into their published work and present data that were not included in their prior publication. Articles published as PharmSights will be by invitation only and undergo the usual peer-review process. Although there is no page limit, authors are advised to be succinct. The article can be divided into the following sections:
Abstract (no more than 200 words), Introduction, Materials and Methods (if any), Results and Discussion.
Viewpoints. The Journal will also publish invited "Viewpoint" articles from time to time. The editors will identify "hot and stimulating" topics and then commission experts in the field to write short articles. Viewpoints will reflect the current state of knowledge and the author’s own personal views about the topic. Articles published as Viewpoints will also go through the standard peer-review process. The Viewpoints should conform to the Journal guidelines and should have a Title page with a running title and 6 keywords and an Abstract (150-250 words) and text.
Review Articles. The Journal will publish comprehensive scholarly reviews in any area relevant to Pharmacological Sciences. Mini-reviews on “hot” emerging topics are also encouraged. All Review Articles are expected to also conform to the Journal guidelines and should have a Title page, an Abstract (250 words) and text. The text may be subdivided as deemed appropriate and supported by high-quality illustrations. The abbreviations should be defined at the time of their first use.
Peer-Review Process. Molecular and Cellular Pharmacology has an international editorial board. When a manuscript is received, it is immediately assigned to an editorial board member who will invite two or more external reviewers to evaluate the manuscript. The Journal endeavors to provide thorough evaluation of all manuscripts and editorial decisions are rendered in a timely manner. Revised Manuscripts. Authors should submit revised version of their manuscripts within three months following editorial decisions. Authors are advised that after 3 months, the revised version will be considered a new submission.
Copyright. Molecular and Cellular Pharmacology, as an open access journal, allows unrestricted ethical use and distribution of its published contents in any medium. By submitting a manuscript for publication consideration in Molecular and Cellular Pharmacology, all authors accept the Journal’s policy of open access and unrestricted use/distribution of their work, if published.
Publication Charges. Molecular and Cellular Pharmacology is an open access journal that endeavors to provide cost-free access to its published contents. Molecular and Cellular Pharmacology does not levy publication charges of any kind including for example, page charges, submission fee and/or publication fees; all accepted articles are published without cost to authors.
Disclaimer. Although every effort is made to ensure accuracy of published work, the Journal (including its staff, editors, publishing service, publishers) do not take legal responsibility for any errors or omissions.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
A single submission file contains the entire manuscript (including figures and tables) in PDF format.
- The text is single or double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses).
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
Names and email addresses of at least 3-5 potential referees are provided.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.